GLP-1 & Metabolic

BAM-15 Overview BAM-15 is a mitochondrial protonophore researched for its potential role as a mitochondrial uncoupler. In laboratory settings, BAM-15 […]

Liraglutide Overview Liraglutide is a synthetic peptide analog of the human glucagon-like peptide-1 (GLP-1). In laboratory research, Liraglutide is investigated

5-Amino-1MQ Overview 5-Amino-1MQ (5-Amino-1-methylquinolinium) is a small molecule research compound studied for its potential to inhibit nicotinamide N-methyltransferase (NNMT), an

SLU-PP-332 Overview SLU-PP-332 is a novel research compound classified as a REV-ERB agonist. It is being investigated in laboratory settings

Cagrilintide Overview Cagrilintide is a synthetic research peptide classified as an amylin analog. It is studied in laboratory environments for

MOTS-c Overview MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a mitochondrial-derived research peptide that plays a

Tirzepatide Overview Tirzepatide is a synthetic research peptide that functions as a dual agonist for the glucose-dependent insulinotropic polypeptide (GIP)

Semaglutide Overview Semaglutide is a synthetic research peptide that functions as a glucagon-like peptide-1 (GLP-1) receptor agonist. It is widely

Retatrutide Overview Retatrutide is an investigational research peptide that acts as a novel triple agonist targeting the GLP-1 (glucagon-like peptide-1),